Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 18 | 4 | CHEMISTRY, ANALYTICAL//TOXICOLOGY//ENVIRONMENTAL SCIENCES | 697102 |
| 305 | 3 | NSAIDS//TOXIC EPIDERMAL NECROLYSIS//NON STEROIDAL ANTI INFLAMMATORY DRUGS | 41294 |
| 923 | 2 | CYCLOOXYGENASE 2//COX 2//CYCLOOXYGENASE | 11303 |
| 25218 | 1 | 15 HYDROXYPROSTAGLANDIN DEHYDROGENASE//15 PGDH//OATP2A1 | 311 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | 15 HYDROXYPROSTAGLANDIN DEHYDROGENASE | authKW | 943214 | 7% | 42% | 22 |
| 2 | 15 PGDH | authKW | 636656 | 5% | 37% | 17 |
| 3 | OATP2A1 | authKW | 405359 | 1% | 100% | 4 |
| 4 | PROSTAGLANDIN TRANSPORTER | authKW | 342010 | 3% | 38% | 9 |
| 5 | 15 HYDROXYPROSTAGLANDIN DEHYDROGENASE 15 PGDH | authKW | 135118 | 1% | 67% | 2 |
| 6 | INTRACELLULAR PROSTAGLANDIN E2 | authKW | 135118 | 1% | 67% | 2 |
| 7 | NUCLEIC SEQUENCE | authKW | 135118 | 1% | 67% | 2 |
| 8 | PROSTAGLANDIN DEHYDROGENASE | authKW | 133334 | 2% | 26% | 5 |
| 9 | 115 HYDROXYPROSTAGLANDIN DEHYDROGENASE | authKW | 101340 | 0% | 100% | 1 |
| 10 | 15 HYDROPROSTAGLANDIN DEHYDROGENASE 15 PGDH | authKW | 101340 | 0% | 100% | 1 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Biochemistry & Molecular Biology | 737 | 41% | 0% | 129 |
| 2 | BIOLOGY, MISCELLANEOUS | 356 | 1% | 0% | 2 |
| 3 | Biophysics | 347 | 13% | 0% | 40 |
| 4 | Endocrinology & Metabolism | 331 | 14% | 0% | 42 |
| 5 | Cell Biology | 286 | 17% | 0% | 53 |
| 6 | MEDICINE, MISCELLANEOUS | 253 | 1% | 0% | 2 |
| 7 | Oncology | 205 | 15% | 0% | 47 |
| 8 | Pharmacology & Pharmacy | 196 | 17% | 0% | 52 |
| 9 | Physiology | 54 | 5% | 0% | 17 |
| 10 | Gastroenterology & Hepatology | 34 | 4% | 0% | 12 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | CARDIOVASCFALK CARDIOVASC | 101340 | 0% | 100% | 1 |
| 2 | DIGEST TEST | 101340 | 0% | 100% | 1 |
| 3 | FRAUENKLIN ALBERT WEITZER STR 33 | 101340 | 0% | 100% | 1 |
| 4 | IHF HORMONE FERTILITY | 101340 | 0% | 100% | 1 |
| 5 | MODELING HLTH RER | 101340 | 0% | 100% | 1 |
| 6 | MOL IMMUNOLNIKOLAUS FIEBIGER | 101340 | 0% | 100% | 1 |
| 7 | PHARM MED CHEM PHARMACOL | 101340 | 0% | 100% | 1 |
| 8 | SURGUROPHARMACOL ENDOUROL | 101340 | 0% | 100% | 1 |
| 9 | CANC UK COLORECTAL TUMOUR BIOL GRP | 81065 | 1% | 20% | 4 |
| 10 | MED ONCOLSTATE BIOTHER YCANC | 50669 | 0% | 50% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | PROSTAGLANDINS LEUKOTRIENES AND MEDICINE | 7396 | 3% | 1% | 8 |
| 2 | PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS | 7220 | 5% | 0% | 15 |
| 3 | PROSTAGLANDINS & OTHER LIPID MEDIATORS | 6435 | 4% | 1% | 11 |
| 4 | PROSTAGLANDINS | 5913 | 3% | 1% | 9 |
| 5 | CANCER PREVENTION RESEARCH | 1271 | 1% | 0% | 4 |
| 6 | JOURNAL OF APPLIED CARDIOLOGY | 702 | 0% | 1% | 1 |
| 7 | CLINICAL RESPIRATORY PHYSIOLOGY-BULLETIN EUROPEEN DE PHYSIOPATHOLOGIE RESPIRATOIRE | 631 | 0% | 1% | 1 |
| 8 | ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS | 578 | 3% | 0% | 10 |
| 9 | AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY | 538 | 2% | 0% | 6 |
| 10 | KOSMICHESKAYA BIOLOGIYA I AVIAKOSMICHESKAYA MEDITSINA | 516 | 1% | 0% | 2 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |